Perioperative cardiac complications

Medical Clinics of North America

Volumn 85, Issue 5, 2001, Pages 1151-1169

  Weitz, Howard H ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; CLOPIDOGREL; DESFLURANE; DEXMEDETOMIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRILAT; ESMOLOL; FENOLDOPAM; FIBRINOLYTIC AGENT; GLYCERYL TRINITRATE; ISOFLURANE; LABETALOL; LOW MOLECULAR WEIGHT HEPARIN; METHYLDOPA; METOPROLOL; MIVAZEROL; NARCOTIC AGENT; NICARDIPINE; NIFEDIPINE; NITROPRUSSIDE SODIUM; PROPRANOLOL; SEVOFLURANE; UNINDEXED DRUG;

ANESTHESIA COMPLICATION; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; DRUG WITHDRAWAL; HEART DISEASE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HUMAN; HYPERTENSION; HYPOTENSION; INCIDENCE; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; SURGICAL MORTALITY; SURGICAL RISK; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT INDICATION; WITHDRAWAL SYNDROME;

EID: 0034828471     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(05)70370-9     Document Type: Article

References (63)

1. Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I
2. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction - Pharmacological approaches
3. Operative procedures not involving the heart after percutaneous transluminal coronary angioplasty
4. Practice guidelines for pulmonary artery catheterization
5. Assessment of the treatment effect of enoxaparin for unstable angina/non-Q wave myocardial infarction. TIMI IIB-ESSENCE meta-analysis
6. Myocardial infarction after noncardiac surgery
7. In-hospital and long-term mortality in male veterans following noncardiac surgery
8. Antithrombotic agents in coronary artery disease
9. The post-operative electrocardiogram and creatine kinase: Implications for diagnosis of myocardial infarction after noncardiac surgery
10. Risks for postoperative congestive heart failure
11. Intraoperative blood pressure: What patterns identify patients at risk for postoperative complications?
12. Risk for postoperative congestive heart failure: A review of 40 cases
13. Pathology of fatal perioperative myocardial infarction: Implications regarding pathophysiology and prevention
14. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery
15. Cardiac risk of noncardiac surgery: Influence of coronary disease and type of surgery in 3368 operations
16. Angiographic correlates of cardiac death and myocardial infarction complicating major nonthoracic vascular surgery
17. Multicenter study of general anesthesia: III. Predictors of severe perioperative adverse outcomes
18. Risk of noncardiac operation in patients with defined coronary artery disease: The Coronary Artery Surgery Study (CASS) Registry experience
19. Perioperative maintenance of normothermia reduces the incidence of morbid events
20. Risk factors in patients undergoing major nonvascular abdominal operations that predict perioperative myocardial infarction
21. Importance of generalized defective perception of painful stimuli as a cause of silent myocardial ischemia in chronic stable angina pectoris
22. Assessment of perioperative risk
23. Risks of general anesthesia and elective operation in the hypertensive patient
24. Multifactorial index of cardiac risk in noncardiac surgical procedures
25. Should a moratorium be placed on sublingual nifedipine?
26. Effect of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
27. Late results of coronary bypass in patients with infrarenal aortic aneurysms: The Cleveland Clinic experience
28. The epidemiology of heart failure: The Framingham study
29. Abrupt cessation of treatment in hypertension: Consideration of clinical features, mechanisms, prevention, and management of the discontinuation syndrome
30. Hypertension, admission blood pressure and perioperative cardiovascular risk
31. Outcome of noncardiac operations in patients with severe coronary artery disease successfully treated preoperatively with coronary angioplasty
32. Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction
33. Catastrophic outcomes of noncardiac surgery soon after coronary stenting
34. Importance of long-duration postoperative ST-segment depression in cardiac morbidity after vascular surgery
35. Central modulation of pain perception in patients with silent myocardial ischemia
36. Clinical effects of beta adrenergic blockade in chronic heart failure: A meta analysis of double-blind, placebo-controlled, randomized trials
37. Perioperative cardiac morbidity
38. Long-term cardiac prognosis following noncardiac surgery
39. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery
40. Perioperative myocardial ischemia in patients undergoing noncardiac surgery: I. Incidence and severity during the 4 day perioperative period
41. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery
42. Beneficial effects of the alpha-2 adrenoceptor agonist mivazerol on hemodynamic stability and myocardial ischemia
43. Consensus recommendations for the management of chronic heart failure
44. Perioperative assessment and management of risk from coronary artery disease
45. Pathophysiology of congestive heart failure
46. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
47. The effect of bisoprolol on perioperative mortality and myocardial infarction in high risk patients undergoing vascular surgery
48. Studies of anesthesia in relation to hypertension: I. Cardiovascular responses of treated and untreated patients
49. The effect of heart rate control on myocardial ischemia among high risk patients after vascular surgery
50. 1999 Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. Executive summary and and recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)
51. Perioperative activation of hemostasis in vascular surgery patients
52. Does perioperative myocardial ischemia lead to postoperative myocardial infarction?
53. Further observations on perioperative myocardial ischemia
54. Does chronic treatment with calcium entry blocking drugs reduce perioperative myocardial ischemia?
55. Analysis of risk factors for myocardial infarction and cardiac mortality after major vascular surgery
56. Myocardial reinfarction after anesthesia and surgery
57. The effect of digoxin on mortality and morbidity in patients with heart failure
58. Failure of intravenous nitroglycerine to prevent intraoperative myocardial ischemia during fentanyl-pancuronium anesthesia
59. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: Results of the PROVED trial
60. Prophylactic atenolol reduces postoperative myocardial ischemia
61. Perioperative hypertension: An overview
62. Hemodynamic instability after carotid endarterectomy: Risk factors and associations with operative complications
63. Beta blockers during and after myocardial infarction: An overview of the randomized trials